首页> Frontiers in immunology> Assessing the predictive value of smoking history for immunotherapy outcomes in bladder cancer patients.

Assessing the predictive value of smoking history for immunotherapy outcomes in bladder cancer patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jianqiu,Kong

第一单位： Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.

作者： Jianqiu,Kong ^[1] ; Yitong,Zou ^[1] ; Hua,Zhou ^[2] ; Yi,Huang ^[1] ; Ying,Lin ^[3] ; Shuogui,Fang ^[4] ; Zhijian,Chen ^[1] ; Junjiong,Zheng ^[1] ; Yaqiang,Huang ^[5] ; Zefeng,Shen ^[6] ; Weibin,Xie ^[1] ; Xinxiang,Fan ^[1]

作者单位： Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. ^[1] Department of Urology, Pu 'er People's Hospital of Yunnan Province, Pu'er, Yunnan, China. ^[2] Department of Endocrinology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. ^[3] Department of Radiotherapy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. ^[4] Department of Urology, Zhongshan City People's Hospital, Sunwen East Road, Zhongshan, Guangdong, China. ^[5] Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China. ^[6]

关键词 PD-L1 expression bladder cancer clinical outcomes immunotherapy smoking history